| Market Cap | ₹1,166Cr |
| ROE | 17.30% |
| P/E Ratio(TTM) | 18.82 |
| EPS(TTM) | 9.26 |
| P/B Ratio | 4.61 |
| Dividend Yield | 1.42% |
| Industry P/E | 39.23 |
| Book Value | 37.81 |
| Debt to Equity | 0.03 |
| Face Value | 2 |
| Managing Director | Manish Gupta |
| Founded | 1978 |
| NSE Symbol | JAGSNPHARM |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 40.07 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 35.82 | ||
| Wockhardt | NA (0.00%) | -451.61 | ||
| Cohance Lifesciences | NA (0.00%) | 50.91 |